๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cyclo-oxygenase 2 inhibition in colorectal cancer therapy

โœ Scribed by R. D. Church; J. W. Fleshman; H. L. McLeod

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
297 KB
Volume
90
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Early expression of cyclo-oxygenase-2 du
Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis
โœ Hao, Xingpei; Bishop, Anne E.; Wallace, Marina; Wang, Hong; Willcocks, Teresa C. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 328 KB

Regular administration of non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the incidence of colorectal cancer by targeting cyclo-oxygenase-2 (Cox-2), a key enzyme in arachidonic acid metabolism. To evaluate the role of Cox-2 in sporadic colorectal cancer development, Cox-2 expression was in

Coordinate up-regulation of low-density
Coordinate up-regulation of low-density lipoprotein receptor and cyclo-oxygenase-2 gene expression in human colorectal cells and in colorectal adenocarcinoma biopsies
โœ Donald F. Lum; Kenneth R. McQuaid; Vicki L. Gilbertson; Millie Hughes-Fulford ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 115 KB ๐Ÿ‘ 2 views

Many colorectal cancers have high levels of cyclo-oxygenase 2 (COX-2), an enzyme that metabolizes the essential fatty acids into prostaglandins. Since the low-density lipoprotein receptor (LDLr) is involved in the uptake of essential fatty acids, we studied the effect of LDL on growth and gene regul